Delivery Order SPE2DR25D9144-SPE2DR26FDJS5
Award Date 2/10/26
Potential Completion Date 3/4/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,174.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4mL). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating the contractor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,881.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% Vial 4ML. This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $2,444.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for OMIDRIA 1-0.3% vials in 4 mL quantities. This delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, represents a firm fixed-price purchase with no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $2,494.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL. DMS...
- The Defense Logistics Agency issued a $4,764.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,222.27 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Omidria 1-0.3% vial 4ml. The award, issued on January 27, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of February 18, 2026, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a $3,320.62 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to Department of Defense...
- The Defense Logistics Agency issued a $1,094.96 delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the distribution of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to Department of Defense...
- The Defense Logistics Agency issued a $3,184.64 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a DLA-administered indefinite delivery contract program with a $499.9 billion ceiling across multiple regional prime vendor contractors, structured to provide firm...